Release Date: 01/08/14 13:11 Summary: Investor Presentation - 1 August 2014 Price Sensitive: No Download Document 2.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%